Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Comparative Analysis: Peptides vs Surgical and Conservative Interventions

Conservative (PT + NSAIDs) Symptom management, no tissue repair 6–12 weeks (if effective) None. Relies on existing blood supply High (55% remain symptomatic) Does not address avascularity; effective only for minor peripheral tears with intact blood supply Arth

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Conservative (PT + NSAIDs)
  • Symptom management, no tissue repair
  • 6–12 weeks (if effective)
  • None. Relies on existing blood supply
  • High (55% remain symptomatic)
  • Does not address avascularity; effective only for minor peripheral tears with intact blood supply
  • Arthroscopic Labral Repair
  • Surgical reattachment with suture anchors
  • 3–6 months (post-surgical recovery)
  • Depends on preserved native vasculature
  • Moderate (15–20% revision surgery rate)
  • Gold standard for mechanical restoration but requires adequate vascularity for healing. Older patients or degenerative tears often fail
  • BPC-157 (250–500mcg daily)
  • VEGF-mediated angiogenesis
  • 2–4 weeks (early effects), 8–12 weeks (structural)
  • Stimulates new capillary formation
  • Unknown. Limited human trial data
  • Most evidence from animal models; human case reports suggest anti-inflammatory and pain-reduction effects within 2–4 weeks
  • TB-500 (2–5mg twice weekly)
  • Actin modulation, cell migration, MMP upregulation
  • 4–8 weeks
  • Indirect. Supports tissue remodeling
  • Strongest evidence for tendon injuries; labral application extrapolated from connective tissue repair studies
  • Combined BPC-157 + TB-500
  • Dual pathway: angiogenesis + remodeling
  • 3–6 weeks (symptom reduction), 12+ weeks (tissue maturation)
  • Directly stimulates neovascularization
  • Unknown. No long-term cohort data
  • Theoretical synergy supported by mechanism; lack of Phase 3 human trials limits clinical adoption
  • The honest comparison: peptides do not replace surgery for full-thickness labral tears with mechanical instability (hip locking, catching, severe range-of-motion loss). They address the biological healing deficit. Vascular insufficiency. That conservative therapy cannot fix and surgery assumes is present. If the tear occurred in young, healthy tissue with preserved blood supply, peptides may support repair. If the tear exists in degenerative, avascular tissue in a 50-year-old with femoral acetabular impingement (FAI), peptides alone won't restore mechanical function.